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Abstract
Introduction. Gestational trophoblastic diseases (GTD) are
a spectrum of tumors with a various of biological behavior
and potential for metastases. It consists of hydatiform mole,
invasive mole, choriocarcinoma and placental site tropho-
blastic tumor. Choriocarcinoma presents a very aggressive
tumor with high malignant potential. Case report. We pre-
sented the two cases of choriocarcinoma with brain metas-
tases. The first one was manifested by neurological deterio-
ration as the first sign of metastasis, while the second pa-
tient had firstly metrorrhagia and in the further couse neu-
rological disturbances that suggested the presence of brain
tumor. In both cases we applied a combined treatment of
surgery, chemotherapy and radiation therapy. Both patient
survived with high quality of life. Conclusion. A successful
outcome of brain metastases of choriocarcinoma was ob-
tained by the use of a combined treatment of surgery, che-
motherapy and radiation therapy. In cases of young women
with brain metastases, gynecological malignancy should be
always considered.
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Apstrakt
Uvod. Gestacijske trofoblastne bolesti predstavljaju spektar
tumora sa razliÿitim biološkim ispoljavanjem i metastatskim
potencijalom. Obuhvataju hidatiformnu molu, invazivnu
molu, horiokarcinom i tumor placentnog ležišta. Horiokar-
cinom predstavlja agresivni tumor sa visokim malignim po-
tencijalom. Prikaz bolesnika. U radu su prikazana dva bo-
lesnika sa horiokarcinomom i metastatskim promenama u
mozgu. Kod prvog bolesnika bolest se manifestovala neu-
rološkom simptomatologijom kao prvim znakom horiokar-
cinoma, dok je kod druge bolesnice najpre bilo prisutno kr-
varenje iz materice, a u daljoj fazi javili su se neurološki po-
remeýaji koji su ukazivali na prisustvo tumora u mozgu.
Kod obe bolesnice primenjeno je kombinovano leÿenje (hi-
rurško odstranjenje tumora, hemio- i radioterapija) koje je
dovelo do izleÿenja. Zakljuÿak. Uspešno leÿenje metastaza
na mozgu poreklom od horiokarcinoma postignuto je pri-
menom hirurškog zbrinjavanja, hemioterapije i radioterapije.
Kod mlaĀih bolesnika sa metastatskim promenama na moz-
gu, uvek bi trebalo razmišljati diferencijalno-dijagnostiÿki i o
ginekološkom malignitetu.
Kljuÿne reÿi:
horiokarcinom; neoplazme, metastaze; mozak,
neoplazme; dijagnoza; leÿenje lekovima; radioterapija;
neurohirurške procedure; leÿenje, ishod.
Introduction
Gestational trophoblastic diseases (GTD) consist of
neoplasms of trophoblasts and conditions predisposing the
neoplasm. These diseases include hydatidiform mole, inva-
sive mole, choriocarcinoma and placental-site trophoblastic
tumor 
1. Choriocarcinoma is a malignant form of GTD.
Clinically, it is most frequently presented as abnormal uter-
ine hemorrhage after abortion or hydatidiform mole. Consid-
ering high malignancy potential, the metastases are frequent,
and mostly found in the lungs, vagina, brain, kidneys and
ovaria 
2. Sometimes, the initial manifestations of this disease
are just the symptoms related to metastatic focus 
3. Cerebral
metastases are found in 10–20% of choriocarcinoma cases,
and usually manifested as intracerebral or subdural hema-
toma, vascular occlusion, arterial aneurysm or spinal epidu-
ral hematoma 
4.
We reported two cases of metastatic brain choriocarci-
noma. In the first case brain metastasis gave first sign of the
disease, which led to prompt treatment with fertility sparing
at the end. In the second case brain metastasis was discov-
ered a year after the first signs of choriocarcinoma which ledVolumen 70, Broj 10 VOJNOSANITETSKI PREGLED Strana 969
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to a higher number of chemotherapeutical cures with no fer-
tility sparing. This emphasizes the necessity of complete
body screening, including computed tomography (CT) of the
brain when the diagnosis of choriocarcinoma is made.
Case report
Case 1
A 19-year-old female patient was admitted to the Insti-
tute of Neurosurgery, Clinical Center of Serbia, as an emer-
gency due to spontaneous right parietal intracerebral hema-
toma whose presence was verified by computerized CT of
the brain (Figure 1).
A week before admission the patient had a headache as-
sociated with vision impairment. On the admission day, the
patient suddenly lost consciousness. Neurological examina-
tion revealed uncommunicative patient with circular pupil
responding to light, as well as dextral paresis of the lower
level. Her medical history recorded one vaginal birth. After 3
days of admission, her condition was abruptly aggravated
with respiratory arrest, and appropriate cardiopulmonary re-
suscitation (CPR) measures were applied. Control brain CT
showed the enlargement of hematoma mass and cerebral
edema, due to which the patient immediately operated on and
hematoma evacuated. Control brain CT revealed hypodense
changes in the remaining hematoma, i.e. tumor or malforma-
tions of cerebral blood vessels, requiring digital subtraction
pan-angiography which ruled out the presence of vascular
malformation as the cause of hemorrhage. Eight days later,
the patient was reoperated, and the right paraventricular tu-
mor of about 2 cm in size removed (Figure 2). After opera-
tion, the patient was aware with the passing dexter hemipare-
sis and psychoorganic syndrome of the mid degree.
Given that preliminary histopathological examination
aroused suspicion about the choriocarcinoma, CT of the
chest, abdomen and small pelvis was carried out immedi-
ately, which demonstrated multiple circular soft-tissue
changes scattered in both lungs. Other findings were regular.
Subsequently, blood tests for alpha-fetoprotein and beta hCG
were carried out, revealing the serum beta hCG concentra-
tion over 225000.0 IU/L (less than 5 is normal), and alpha-
fetoprotein of 0.5 ȝg/L (13.4 ȝg/L is normal). Immunohisto-
chemical examination of the tumor confirmed the choriocar-
cinoma.
The Medical Board decided to introduce 20 cGy radia-
tion therapy. The patient tolerated radiotherapy well, with no
antiedematous therapy, and consciously but slightly slow
from psychic aspect. After completed radiotherapy, the pa-
tient was transported to the Clinic of Gynecology and Ob-
stetrics because of metastatic pulmonary changes, further di-
agnostics and treatment of choriocarcinoma. Upon Tropho-
blastic Diseases Board consideration, it was concluded that
the patient had brain choriocarcinoma and metastases to
lungs without any evidence of underlying uterine disease.
Considering that it was the patient with FIGO stage IV,
WHO 17, with beta hCG value of 470,235 IU/L, it was de-
cided to employ chemotherapy (etoposide, methotrexate, ac-
tinomycin D, cyclophosphamide and Oncovin – EMACO).
Until a complete remission  (41 days), the patient was ad-
ministered two therapies according to this protocol. The pa-
tient was discharged recovered with preserved fertility. Neu-
rological status on discharge and two months later was com-
pletely normal.
Case 2
A 35-year-old female patient was admitted to the Clinic
of Gynecology and Obstetrics, Clinical Center of Serbia, in
December 2010 due to previous histopathologically verified
uterine choriocarcinoma upon exploration curettage which
had been performed for abundant uterine bleeding. Her per-
sonal anamnesis reads that she had two deliveries by Ce-
sarian section in 2002 and 2008. Between two births, the pa-
Fig. 1 – Computed tomography (CT) on admission showed a right intracerebral hematoma.
Fig. 2 – Upon tumor evacuation computed tomography (CT) verified the complete regression of changes.Strana 970 VOJNOSANITETSKI PREGLED Volumen 70, Broj 10
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tient had one complete molar pregnancy (complete hydatid
mole) which, because of being refractory, was treated by
methotrexate. On admission, ultrasonography verified the
isthmic-cervical uterine tumor and magnetic resonance im-
aging (MRI) of the abdomen and small pelvis corroborated
the presence of 96 u 77 u 66 mm tumor with bilateral
parailiac and inguinal lymphadenopathy. The chest X-ray
was normal. The patient was staged by Trophoblastic Dis-
eases Board as WHO 9, FIGO I, and urgent hysterectomy
with bilateral ovarian conservation was indicated. Immedi-
ately prior to surgery, beta hCG was 188,871 IU/L. In post-
operative course, the patient received one course of chemo-
therapy by EMACO Protocol. Control MRI of the abdomen
and chest detected metastatic changes to lungs, on what ac-
count the patient was restaged by the Board as FIGO 3,
WHO 10, and accordingly, two courses of EMACO chemo-
therapy were added; this new administration resulted in 90-
day remission of the disease and complete normalization of
beta subunits. The patient was rehospitalized in May 2010
due to vertigo and occasional vision field incidents, what
aroused the suspicion to metastatic changes in the brain.
Neurological status revealed discrete dexter hemiparesis.
Endocranial CT verified the presence of the right parietooc-
cipital tumor (Figure 3).
Fig. 3 – Computed tomography (CT) finding indicated a
right parietooccipital tumor change.
Repeated rise of beta hCG was 2,284 IU/L and the pa-
tient received IV, V and VI course of chemotherapy, and
neurosurgical examination (MRI, liquor puncture) found
congenital cavernous angioma. Chemotherapy resulted in re-
gression of brain tumor and normalization of beta subunits.
The patient was discharged recovered in July 2010, and ad-
vised by the neurosurgeon to have her control done in 3
months. At the beginning of October, the patient manifested
again the same symptoms as in earlier hospitalization. Based
on endocranial CT scanning and symptoms (vertigo, dizzi-
ness and crural hemiparesis to the left), the neurosurgeon de-
cided to operate on her. In addition, the increase of blood
beta hGC level was increased again. Upon tumor extirpation,
the patient was again transferred to the Clinic of Obstetrics
and Gynecology to receive VII and VIII course of EMACO
chemotherapy. A histopathological finding indicated the
metastatic brain choriocarcinoma which was hemorrhagi-
cally and necrotically modified. According to the decision
made by Neurosurgery Board, palliative 20 cGy radiotherapy
was applied. After radiation therapy, the patient went well,
but her fertility was not preserved. Neurological status on
discharge was normal.
Discussion
The risk of choriocarcinoma is rare before the age of 20
years, and it is significantly increased in individuals over 40
years 
5. Both presented cases are beyond typical etiology of
choriocarcinoma.
GTDs are most frequent in Asian countries with the an-
nual incidence of 1/2000 of all pregnancies (births and mis-
carriages). Recent literature has described only 150 chorio-
carcinomas metastasized to the lungs and brain 
6. In diagno-
sis of choriocarcinoma, metastatic changes are detected in
about 30% of patients 
7. Due to hematogenic spread of tro-
phoblastic tissue, the metastases are manifested very early,
and their symptoms are usually related to bleeding from
metastatic focus. Staging of patients based on WHO and
FIGO criteria allows for rapid orientation and prompt treat-
ment. The WHO criteria suggest that any patient with WHO
score over 8 is considered at high risk and the initiation of
treatment is suggested as soon as possible without additional
therapy such as surgery or radiation therapy. Both presented
cases had high WHO score (17 and 9, respectively).
Treatment of choriocarcinoma consists of polychemo-
therapy. Initiation of EMACO radiotherapy is the first treat-
ment choice. Surgical treatment is used in cases of local,
chemoresistant metastatic focus and recurring disease. Nev-
ertheless, some studies show that surgical treatment of meta-
static changes shortens the time of cure 
8.
Application of radiotherapy in cases of metastatic brain
choriocarcinoma is controversial. Certain authors suggest 30
to 40 Gy radiotherapy along with chemotherapy. Study on 78
subjects affected by choriocarcinoma with brain metastases
demonstrated survival of 50% in patients treated both by
chemo- and radiotherapy vs 24% survival rate in those
treated with chemotherapy only 
7, 8.
Our experience in both cases show that the synergism
of chemotherapy, surgical evacuation of tumorous changes,
and, finally, radiotherapy is a pathway to preservation of re-
productive ability and healing of patients.
Conclusion
Treatment of GTD with metastatic changes in the brain
is a great challenge. Nevertheless, the incidence of cure is
high. The first treatment choice is chemotherapy and surgery,
and in cases where it is required, radiotherapy, as well.
Given high metastatic potential, choriocarcinoma should be
considered in cases of intracranial hemorrhage with the un-
usual location in reproductive women. Histopathological
findings and measurements of beta hCG are necessary for
making the diagnosis of choriocarcinoma.Volumen 70, Broj 10 VOJNOSANITETSKI PREGLED Strana 971
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